Introduction: The Measure Yourself Medical Outcome Profile (MYMOP 2) is being used as a generic tool to document its effectiveness, together with the evaluation of health systems and their interventions. Objective: To assess the cultural adaptation and reproducibility of the Measure Yourself Medical Outcome Profile (MYMOP2) questionnaire in a sample of patients undergoing cardiac surgery. Methods: The study sample consisted of 50 patients undergoing cardiac surgery for myocardial and valve revascularization, which were recruited from the cardiac ICU of a private hospital in Maceió, Alagoas. The MYMOP2 questionnaire was initially translated into Brazilian Portuguese. Cultural and conceptual adaptation were performed, so that patients were able to understand questions. All patients answered this instrument twice, on the same day, with two different interviewers, with an interval of 30 minutes between the interviews. After one day, the questionnaire was repeated on a second visit. This process was carried out with MYMOP and MYMOP2 FOLLOW UP. Reproducibility and validity were tested. Results: Cultural adaptations were made, so that the final version was obtained. Spearman correlation coefficient for MYMOP2 was 1 and FOLLOW UP was 0.794, p < 0.001. There were moderate correlations with the domains of the EQ-5D. MYMOP2 was validated and supported by a significant correlation between change scores and MYMOP2 change scores and the ability to detect an improvement in acute conditions. Conclusion: MYMOP2 questionnaire is reproducible, easy to understand and quick to apply. It should be included and used in any Brazilian study with the objective to assess disease impact over time.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.